Search

Author/Creator Rendell, Marc

14. The time to offer treatments for COVID-19. (4th May 2021)

Authors:
Ngo, Binh T.; Marik, Paul; Kory, Pierre; Shapiro, Leland; Thomadsen, Raphael; Iglesias, Jose; Ditmore, Stephen; Rendell, Marc; Varon, Joseph; Dubé, Michael; Nanda, Neha; In, Gino; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David E.; Ehresmann, Glenn; Peng, David...
Journal:
Expert opinion on investigational drugs
Issue:
Volume 30:Number 5(2021)
Page Start:
505
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Three-year data from 5 HARMONY phase 3 clinical trials of albiglutide in type 2 diabetes mellitus: Long-term efficacy with or without rescue therapy. (September 2017)

Authors:
Home, Philip D.; Ahrén, Bo; Reusch, Jane E.B.; Rendell, Marc; Weissman, Peter N.; Cirkel, Deborah T.; Miller, Diane; Ambery, Philip; Carr, Molly C.; Nauck, Michael A.
Journal:
Diabetes research and clinical practice
Issue:
Volume 131(2017)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗